CABAZITAXEL DR.REDDY'S cabazitaxel 60 mg/1.5 mL concentrated injection vial

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Bahan aktif:

cabazitaxel, Quantity: 60 mg

Boleh didapati daripada:

Dr Reddys Laboratories Australia Pty Ltd

Borang farmaseutikal:

Injection, concentrated

Komposisi:

Excipient Ingredients: polysorbate 80; citric acid

Laluan pentadbiran:

Intravenous Infusion

Unit dalam pakej:

1

Jenis preskripsi:

(S4) Prescription Only Medicine

Tanda-tanda terapeutik:

Cabazitaxel Dr.Reddy?s in combination with prednisone or prednisolone is indicated for the treatment of patients with metastatic castration resistant prostate cancer previously treated with a docetaxel containing regimen.

Ringkasan produk:

Visual Identification: Clear yellow to brownish-yellow viscous solution.; Container Type: Multiple containers; Container Material: Glass; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status kebenaran:

Registered

Tarikh kebenaran:

2018-07-23